Pancreatic adenocarcinoma: Which assessment to appreciate the resection?;Adénocarcinomes du pancréas: Quel bilan pour apprécier la résécabilité?

Gastroenterologie Clinique et Biologique

Volumn 31, Issue 2, 2007, Pages 216-221

  Barthet, Marc ^a   Moutardier, Vincent ^b   Marciano, Sandrine ^c  

^a Service de Gastroentérologie   (France)

^b Service de Chirurgie Digestive   (France)

^c HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ABDOMINAL RADIOGRAPHY; ARTERIOGRAPHY; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ENDOSCOPIC ECHOGRAPHY; HUMAN; LAPAROSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; POSITRON EMISSION TOMOGRAPHY; REVIEW;

EID: 33947114525     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(07)89361-4     Document Type: Review

References (61)

1. Warshaw AL. Pancreatic carcinoma. New Engl J Med 1992 ;326 :455-65.
2. Faivre J, Grosclaude P, Launoy G et al. Les cancers digestifs en France. Distribution géographique et estimation de l'incidence nationale. Gastroenterol Clin Biol 1997 ;21 :174-80.
3. Shaib YH, Davila JA, El-Serag HB. The epidemiology of pancreatic cancer in the united states : changes below the surface. Aliment Pharmacol Ther 2006; 24: 87-94.
4. Escourrou J., Pagès P, Moreau J, Buscail L. Pronostic du cancer du pancreas.Gastroenterol Clin Biol 2001;25(2 Pt 2):C30-3.
5. Lowenfels AB, Maisonneuve P. Environmental factors and risk of pancreatic cancer. Pancreatology, 2003, 3: 1-7.
6. Di Magno EP, Reber HA, Tempero MA. American gastroenterological association medical position statement. Epidemiology, diagnosis and treatment of ductal adenocarcinoma. Gastroenterology 1999;117:1463-84.
7. Spanknebel K, Conlon KC. Advances in the surgical management of pancreatic cancer. Cancer J 2001; 7:312-23.
8. AGA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 2005;117: 1464-84.
9. Kalser MH, Barkin J, MacIntyre JM. Pancreatic cancer. Assessment of prognosis by clinical presentation. Cancer 1985; 56: 397-402.
10. Ashby K, Lo SK. The role of pancreatic stenting in obstructive ductal disorders other than pancreas divisum. Gastrointest Endosc 1995 ;42 :306-11.
11. Costamagna G, Mutignani M . Pancreatic stenting for malignant obstruction. Dig Liv Dis 2004; 36:635-8.
12. Mannell A, Vanheerden JA, Weiland JH, Ilstrup DM. Factors influencing survival after resection for ductal adenocarcinoma. Ann Surg 1986; 203: 403-7.
13. Riker A, Libutti SK, Bartlett DL. Advances in the early detection, diagnosis, and staging of pancreatic cancer. Surg Oncol 1997; 6:157-69.
14. Schlieman MG, Ho HS, Bold RJ. Utility of tumor markers in determining respectability of pancreatic cancer. Arch Surg 2003;138:951-55.
15. Zins M, Petit E, Boulay-Coletta I, Balaton A, Marty O, Berrod JL. Imagerie de l'adénoarcinome du pancréas. J Radiol 2005;86:759-80.
16. Soriano A, Castells A, Ayuso C, Ayuso JR, De Caralt MT et al. Preoperative staging and tumor resectability assesment of pancreatic cancer. Prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging and angiography. Am J Gastroenterol 2004; 99:492-501.
17. Wray CJ, Ahmad SA, Matthews JB, Lowy AM. Surgery for pancreatic cancer : recent controversies and current practice. Gastroenterology 2005; 128: 1626-41.
18. Bipat S, Phoa S, Van Delden OM, Bossuyt P, Gouma D et al. Ultrasonography, Computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma. J Comput Assist Tomogr 2005;29:438-445.
19. Snady H, Bruckner H, Siegel J, Coopermn A, Neff R, et al. Endoscopic ultrasonographic criteria of vascular invasion by potentially respectable pancreatic tumors. Gastrointest Endosc 1994; 40: 326-33.
20. Hunt GC, Faigel DO. Assessment of EUS for diagnosing, staging, and determining respectability of pancreatic cancer : a review. Gastrointest Endosc 2002;55: 232-7.
21. Palazzo L, Roseau G , Gayet B et al . Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CTscan. Endoscopy 1993;25:143-50.
22. Rosch T, Braig C, Gain T, Feuerbach S, Siewert JR, et al. Staging of pancreatic and ampullary carcinoma by endoscopic utrasonography. Gastroenterology 1992;102:188-99.
23. Buscail L, Pages P, Berthelemy P, Fourtanier G, Frexinos J, Escourrou J. Role of EUS in the management of pancreatic and ampullary carcinoma: a prospective study assessing resectability and prognosis. Gastrointest Endosc 1999;50(1):34-40.
24. Gress FG, Hawes RH, Savides TJ, Ikenberry SO, Cummings O, Kopecky K, et al. Role of EUS in preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest Endosc 1999;50:786-91.
25. Arcidiacono PG, Carrara S. Endoscopic ultrasonography : impact in diagnosis, staging and management of pancreatic tumors. An overview. JOP 2004;5:247-52.
26. Diehl SJ, Lehmann KJ, Sadick M, Lachmann R, Georgi M. Pancreatic cancer : value of dual-phase helical CT in assessing respectability. Radiology 1998;206:373-8.
27. Bluemke DA, Cameron JL, Hruban RH. Potentially respectable pancreatic adenocarcinoma : spiral CT assessment with surgical and pathological correlation. Radiology 2005;197:381-5.
28. Howard TJ, Chin AC, Streib EW, Kopecky KK, Wiebke EA. Value of helicoidal CT computed tomography , angiography, and endoscopic ultrasonography in determining respectability of periampullary carcinoma. Am J Surg 1997;174: 237-41.
29. Nishiharu T, Yamashita Y, Abe Y. Local extension of pancreatic carcinoma : assessment with thin-section helical CT versus with breathhold fat MR imaging - ROC analysis. Radiology 1999; 212: 445-52.
30. Warshaw AL, Tepper JE, Shipley WU. Laparosocopy in the staging and planning of therapy for pancreatic cancer. Am J Surg 1986;151:76-80.
31. Cuschieri A, Hall AW, Clark J, Value of laparoscopy in the diagnosis and management of pancreatic carcinoma. Gut 1978;19:672-7.
32. Rumstadt B, Schwab M, Schuster K. The role of laparoscopy in the preoperative staging of pancreatic carcinoma. J Gastrointest Surg 1997;1:245-50.
33. Fernandez-del-castillo C, Rattner DW, Warshaw AL. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer. Br J Surg 1995; 82:1127-9.
34. Van Dukum EJ, De Wit LT, Van Delden OM. Staging laparoscopy and laparoscopic ultrasonography in more than 400 patients with upper gastrointestinal carcinoma. J Am Coll Surg 1999; 189:459-465.
35. Pfisters PW, Lee JE, Vauthey JN et al. Laparoscopy in the staging of pancreatic cancer. Br J Surg 2001;88:325-37.
36. Rose DM, Delbeke D, Beauchamp RD et al. 18 Fluorodeoxyglucosepositron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg 1999; 229:729-737.
37. Berberat P, Friess H, Kashiwagi M et al. Diagnosis and staging of pancreatic cancer by positron emission tomography. World J Surg 1999;23:882-7.
38. econgrès de l'AFC, Springer Verlag, Paris (1991)
39. Lin JW, Cameron JL, Yeo CJ, Riall TS, Lillemoe KD. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg 2004;8:951-9.
40. Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg 2003;196:954-64.
41. A. Cortes, A. Couvelard, S. Noullet, P. Hammel, C. Francoz, R. Kianmanesh, P. Lévy, P. Ruszniewski, J. Belghiti, A. Sauvanet. La stéatose pancréatique et la surcharge pondérale : de nouveaux facteurs de risque de fistule pancréatique après duodénopancréatectomie céphalique ? Journées Francophones de Pathologie Digestive 2006.
42. Adam U, Makowiec F, Riediger H, Schareck WD, Benz S, Hopt UT. Risk factors for complications after pancreatic head resection. Am J Surg 2004;187:201-8.
43. Makary MA, Winter JM, Cameron JL, Campbell KA, Chang D, Cunningham SC, Riall TS, Yeo CJ. Pancreaticoduodenectomy in the very elderly. J Gastrointest Surg 2006;10:347-56.
44. Muscari F, Suc B, Kirzin S, Hay JM, Fourtanier G, Fingerhut A, Sastre B, Chipponi J, Fagniez PL, Radovanovic A; French Associations for Surgical Research. Risk factors for mortality and intra-abdominal complications after pancreatoduodenectomy: multivariate analysis in 300 patients. Surgery 2006;139:591-8.
45. Brozzetti S, Mazzoni G, Miccini M, Puma F, De Angelis M, Cassini D, Bettelli E, Tocchi A, Cavallaro A. Surgical treatment of pancreatic head carcinoma in elderly patients. Arch Surg 2006;141:137-42.
46. Lightner AM, Glasgow RE, Jordan TH, Krassner AD, Way LW, Mulvihill SJ, Kirkwood KS. Pancreatic resection in the elderly. J Am Coll Surg 2004;198:697-706.
47. Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, Levy A. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg 2000;135:81-7.
48. Sa Cunha A, Rault A, Laurent C, Adhoute X, Vendrely V, Bellannee G, Brunet R, Collet D, Masson B. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J Am Coll Surg 2005;201:359-65.
49. Takahashi S, Ogata Y, Tsuzuki T. Combined resection of the pancreas and portal vein for pancreatic cancer. Br J Surg 1994;81:1190-3.
50. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN et al. Pancreaticoduodenectomy for Cancer of the Head of the Pancreas. 201 patients. Ann Surg 1995; 221: 721-733.
51. Harrison LE, Klimstra DS, Brennan MF. Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg 1996;224:342-7; discussion 347-9.
52. Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 1998;85:611-7.
53. Baulieux J, Adham M, Oussoultzoglou E, De la Roche E, Berthoux N, Bourdeix O et al. Is pancreatectomy with resection of the retro-pancreatic vessels for cancer justified? Chirurgie 1998;123:438-44.
54. van Geenen RC, ten Kate FJ, de Wit LT, van Gulik TM, Obertop H, Gouma DJ. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 2001;129:158-63.
55. Bachellier P, Nakano H, Oussoultzoglou PD, Weber JC, Boudjema K, Wolf PD et al.. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile? Am J Surg 2001;182:120-9.
56. Nakagohri T, Kinoshita T, Konishi M, Inoue K, Takahashi S. Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 2003;186:149-53.
57. Nix GA, Dubbelman C, Srivastava ED, Wilson JH, Boender J, de Jongh FE. Prognostic implications of the localization of carcinoma in the head of the pancreas. Am J Gastroenterol 1991; 86:1027-32.
58. Brunet C, Moutardier V, Di Marino V. The so-called "celio-mesenteric button-hole" region, an anatomico-surgical study J Chir 1993;130:70-3.
59. Baulieux J, Delpero JR. Surgical treatment of pancreatic cancer: curative resections] Ann Chir 2000; 125:609-17.
60. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996;223:273-9.
61. Han SS, Jang JY, Kim SW, Kim WH, Lee KU, Park YH.Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas 2006; 32:271-5.